Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient

被引：0
|
作者：
Maeda, Y
Kuzuya, T
Ota, S
Yamada, K
Kobayashi, T
Hayashi, S
Yokoyama, I
Nakao, A
Nabeshima, T
机构：
[1] Nagoya Univ, Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan
[2] Nagoya Univ, Sch Med, Dept Surg 2, Nagoya, Aichi, Japan
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(02)03413-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2784 / 2787
页数：4
相关论文
共 50 条
  • [21] Neoral (cyclosporine microemulsion) versus sandimmune (cyclosporine) in US liver transplant recipients: Results of the OLN-356 study.
    Pinson, CW
    HEPATOLOGY, 1996, 24 (04) : 193 - 193
  • [22] Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation
    Gusmano, R
    Basile, GC
    Perfumo, F
    Ginevri, F
    Verrina, E
    Famularo, L
    Corbetta, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1985 - 1987
  • [23] Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients
    Johnston, A
    Belitsky, P
    Frei, U
    Horvath, J
    Hoyer, P
    Helderman, JH
    Oellerich, M
    Pollard, S
    Riad, H
    Rigotti, P
    Keown, P
    Nashan, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (06) : 389 - 395
  • [24] Cyclosporine trough levels comparison with AUC during conversion to microemulsion formulation (''Neoral'').
    Heifets, M
    Sellers, P
    Sallas, W
    Browne, B
    Samuels, LA
    Cooney, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3322 - A3322
  • [25] Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation
    Tanaka, K
    Lake, J
    Villamil, F
    Levy, G
    Marotta, P
    Mies, S
    de Hemptinne, B
    Moench, C
    LIVER TRANSPLANTATION, 2005, 11 (11) : 1395 - 1402
  • [26] CYCLOSPORINE-NEORAL IN LIVER-TRANSPLANT RECIPIENTS
    LEVY, G
    ROCHON, J
    FREEMAN, D
    WONG, PY
    BANKS, L
    ROACH, C
    ENGEL, K
    GRANT, D
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2949 - 2952
  • [27] Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients
    Atholl Johnston
    Philip Belitsky
    Ulrich Frei
    John Horvath
    Peter Hoyer
    J. Harold Helderman
    Michael Oellerich
    Stephen Pollard
    Hany Riad
    Paolo Rigotti
    Paul Keown
    Björn Nashan
    European Journal of Clinical Pharmacology, 2004, 60 : 389 - 395
  • [28] Impact of Donor and Recipient Age on Outcomes After Living Donor Liver Transplant
    Nakamura, Tsukasa
    Nobori, Shuji
    Harada, Shumpei
    Sugimoto, Ryusuke
    Yoshikawa, Mikiko
    Ushigome, Hidetaka
    Yoshimura, Norio
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 438 - 442
  • [29] Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: Results from a single center
    Cossu, M
    Satta, R
    Branca, GF
    Pala, PG
    Serra, G
    Satta, RP
    Sorba, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1762 - 1763
  • [30] Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys
    Vincenti, F
    Brennan, TV
    Fuller, TF
    Feng, S
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 50S - 53S
12345